Clinical Trial Update: Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial of autologous myoblast intrasphincteric injections for fecal incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• Autologous myoblast intrasphincteric injection (autologous myoblasts)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Fecal Incontinence | Phase 2, Phase 3 | Status: COMPLETED